Global and United States Point-of-Care or Rapid Testing Market Report & Forecast 2022-2028

Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
Market Analysis and Insights: Global and United States Point-of-Care or Rapid Testing Market
This report focuses on global and United States Point-of-Care or Rapid Testing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Point-of-Care or Rapid Testing market size is estimated to be worth US$ 28290 million in 2022 and is forecast to a readjusted size of US$ 47990 million by 2028 with a CAGR of 9.2% during the review period. Fully considering the economic change by this health crisis, by Type, Blood Glucose Testing accounting for % of the Point-of-Care or Rapid Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Clinics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Point-of-Care or Rapid Testing market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Point-of-Care or Rapid Testing Scope and Market Size
Point-of-Care or Rapid Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Point-of-Care or Rapid Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Point-of-Care or Rapid Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
Segment by Application
Clinics
Hospitals
Laboratory
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Roche
Abbott
Johnson & Johnson
Siemens Healthcare
Danaher
Ascensia
Bio-Rad Laboratories
BioMerieux
ARKRAY
Nova Biomedical
Trividia Health
Quidel
Accriva
OraSure Technologies
Helena Laboratories
A. Menarini Diagnostics
Abaxis (Zoetis)
Ortho Clinical Diagnostics
Phamatech
Chembio Diagnostics
Sinocare
Wondfo
Yuwell
Runbio
KHB
Wuhan EasyDiagnosis Biomedicine
DAAN GENE